S 9788 is a novel triazinoaminopiperidine derivative which does not belong to any of the classes of compounds known to reverse multidrug resistance (MDR). S 9788 was far more potent than verapamil (VRP) in reversing resistance to adriamycin (ADR) in the ADR-selected murine leukaemia cell lines P388/ADR-1 and P388/ADR-10, and the human chronic myelogenous leukaemia K562/R. Fold reversion with S 9788 (5 microM) was, respectively, 3.5, 5.4 and 11.3 times greater than that with VRP (5 microM). S 9788 was also a more potent reversant of ADR resistance in the intrinsically resistant human colon adenocarcinoma COLO 320DM (2.3 fold), and of vincristine (VCR) resistance in the human MDR1 gene-transfected squamous lung carcinoma line S1/tMDR1 (5.6 fold). The activity of S 9788 depended on both the MDR cell line and the cytotoxic agent. S 9788 (50-100 mg/kg/d) administered IP once a day on days 1-4 resulted in a dose-dependent increase in the chemotherapeutic effect of VCR (0.25 mg/kg/d) in P388/VCR - bearing mice and ADR (4 mg/kg/d) in P388/ADR - bearing mice. Increases in antitumor activity were (% T/C) of +20-34% in the P388/ADR model and + 50-78% in the P388/VCR model with respect to cytotoxic agent treatment alone. S 9788 appeared to be devoid of toxicity at its effective doses. The mechanism of action of S 9788 is unknown but S 9788 (0.5-10 microM) induced a dose-dependent increase in ADR accumulation in KB-Al cells and compared to verapamil its effect was twice as active and approximately seven times more potent. We conclude that S 9788 is a novel agent capable of reversing MDR in vitro and in vivo, and whose pharmacological profile warrants its selection as a candidate drug for eventual assessment in the clinic.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF00877238DOI Listing

Publication Analysis

Top Keywords

9788 novel
12
0
11
vitro vivo
8
multidrug resistance
8
novel triazinoaminopiperidine
8
triazinoaminopiperidine derivative
8
9788 potent
8
cytotoxic agent
8
dose-dependent increase
8
bearing mice
8

Similar Publications

Background: Hypotensive episodes detected by 24-hour ambulatory blood pressure (BP) monitoring capture daily cumulative hypotensive stress and could be clinically relevant to cognitive impairment, but this relationship remains unclear.

Methods: We included participants from the Systolic Blood Pressure Intervention Trial (receiving intensive or standard BP treatment) who had 24-hour ambulatory BP monitoring measured near the 27-month visit and subsequent biannual cognitive assessments. We evaluated the associations of hypotensive episodes (defined as systolic BP drops of ≥20 mm Hg between 2 consecutive measurements that reached <100 mm Hg) and hypotensive duration (cumulative time of systolic BP <100 mm Hg) with subsequent cognitive function using adjusted linear mixed models.

View Article and Find Full Text PDF
Article Synopsis
  • The development of antiviral drugs for SARS-CoV-2 is essential due to limited treatment options and the possibility of reinfection after vaccination.
  • Two key viral targets for drug development are the 3'-5' exoribonuclease (ExoN) and the 2'-O-methyltransferase (2'-O-MTase), which are crucial for the virus's survival.
  • The study utilizes target-directed dynamic combinatorial chemistry (tdDCC) to find compounds that inhibit the interactions of essential viral proteins, resulting in a new class of inhibitors that show antiviral activity against coronaviruses.
View Article and Find Full Text PDF
Article Synopsis
  • Extracellular vesicles (EVs) play a crucial role in interactions between plants and microbes, highlighting their importance in biological research.
  • The text addresses the unique challenges faced by researchers studying EVs in plant-microbe systems, emphasizing the need for tailored approaches beyond established guidelines from mammalian studies.
  • Detailed step-by-step suggestions for experimental design, optimization, and quality control are provided to enhance the yield and purity of EV isolation, fostering collaboration and discussion within the broader EV research community.
View Article and Find Full Text PDF
Article Synopsis
  • TRAF3 is an adaptor protein involved in immune signaling pathways, and deficiencies in TRAF3 can lead to serious health issues, like recurrent infections and autoimmune conditions.
  • A recent study reanalyzed genetic data from patients with immune disorders and discovered three new cases of TRAF3 mutations, which had previously been misdiagnosed as common variable immunodeficiency (CVID).
  • These findings highlight the importance of targeted genetic reanalysis in understanding different clinical presentations of TRAF3 deficiency, and they provide new insights for further research on immune-related diseases.
View Article and Find Full Text PDF

Inflammatory bowel disease (IBD) is a chronic and unspecific inflammatory disorder of the gastrointestinal tract, and current treatment options often fail to maintain long-term remission. Studies have shown that propionate level is reduced in fecal samples from patients with IBD. Propionate can ameliorate IBD through intestinal epithelial cells and immune regulation, but its effects on the inflammatory microenvironment and macrophage differentiation have not been widely studied.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!